119 related articles for article (PubMed ID: 8310581)
1. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
Matveev BP; Kariakin OB; Safiullin KN; Figurin KM; Levi DT; Vatin OE
Urol Nefrol (Mosk); 1993; (5):27-9. PubMed ID: 8310581
[No Abstract] [Full Text] [Related]
2. [Intravesical BCG therapy for superficial bladder cancer].
Segawa N; Iwamoto Y; Azuma H; Yamamoto K; Ueda H; Katsuoka Y
Hinyokika Kiyo; 1998 Sep; 44(9):627-31. PubMed ID: 9805666
[TBL] [Abstract][Full Text] [Related]
3. Immunoprophylactic intravesical application of bacillus Calmette-Guerin after transurethral resection of superficial bladder cancer.
Librenjak D; Situm M; Eterovic D; Dogas Z; Gotovac J
Croat Med J; 2003 Apr; 44(2):187-92. PubMed ID: 12698510
[TBL] [Abstract][Full Text] [Related]
4. [The intravesical administration of BCG vaccine in treating recurrent superficial bladder cancer].
Panteleeva ES; Neprina GS; Vatin OE; Kariakin OB; Safiullin KN
Urol Nefrol (Mosk); 1997; (2):29-32. PubMed ID: 9206879
[TBL] [Abstract][Full Text] [Related]
5. [Our experience in treating patients with surface cancer of the bladder].
Matveev BP; Figurin KM; Romanov VA; Cheban NL
Urol Nefrol (Mosk); 1995; (5):35-8. PubMed ID: 8571484
[TBL] [Abstract][Full Text] [Related]
6. [Results of adjuvant intravesical Bacillus Calmette-Guérin therapy for grade 3 superficial bladder cancer].
Yumura Y; Oogo Y; Takase K; Hamano A; Yamashita Y; Noguchi S; Satomi Y
Hinyokika Kiyo; 2004 Nov; 50(11):767-71. PubMed ID: 15628536
[TBL] [Abstract][Full Text] [Related]
7. [The prevention of the recurrence of stage pTa bladder tumors using intravesical instillation of BCG].
Wetzel O; Glemain P; Bouchot O; Guillonneau B; Baron M; Buzelin JM; Auvigne J
Prog Urol; 1993; 3(4):595-607. PubMed ID: 8401620
[TBL] [Abstract][Full Text] [Related]
8. [BCG vaccine and prevention of recurrence of superficial cancer of the bladder. Have all the possibilities been exhausted?].
Vera-Donoso CD; Llopis Minguez B; Gallego Gómez J; Jiménez Cruz JF
Actas Urol Esp; 1989; 13(4):233-5. PubMed ID: 2678933
[No Abstract] [Full Text] [Related]
9. [Intravesical therapy: Influence on superficial bladder cancer recurrence].
García Rodríguez J; Fernández Gómez JM; Escaf Barmadah S; González Alvarez RC; Jalón Monzón A; Martínez Gómez FJ; Sánchez Trilla A; Regadera Sejas J
Arch Esp Urol; 2007; 60(1):36-43. PubMed ID: 17408170
[TBL] [Abstract][Full Text] [Related]
10. [Changes in the activity of natural killer cells in superficial bladder cancer during intravesical BCG therapy].
Samodai L; Dankó K
Orv Hetil; 1992 Sep; 133(36):2283-6, 2291-2. PubMed ID: 1408062
[TBL] [Abstract][Full Text] [Related]
11. [Microdoses of BCG vaccine for prophylaxis in bladder cancer stage T1].
Rivera P; Caffarena E; Cornejo H; Del Pino M; Fonerón A; Haemmersli J; Sepúlveda M; Ubilla A
Actas Urol Esp; 1993 Apr; 17(4):243-6. PubMed ID: 8342414
[TBL] [Abstract][Full Text] [Related]
12. [Prophylaxis of superficial bladder cancer with 1 mg of intravesical BCG: comparison with other doses].
Corti Ortíz D; Rivera Garay P; Avilés Jasse J; Hidalgo Carmona F; MacMillan Soto G; Coz Cañas LF; Vargas Delaunoy R; Susaeta Saénz de San Pedro R
Actas Urol Esp; 1993 Apr; 17(4):239-42. PubMed ID: 8342413
[TBL] [Abstract][Full Text] [Related]
13. [Intracavitary BCG instillation in superficial bladder cancer].
Zhang DY; Xu LX; Zhang JL
Zhonghua Wai Ke Za Zhi; 1986 Nov; 24(11):683-4, 701. PubMed ID: 3568884
[No Abstract] [Full Text] [Related]
14. [Mechanism of preventing the recurrence of bladder carcinoma by intravesical instillation of BCG plus IL-2].
Wen R; Zhou G; Xie S; Lian B; Sun X; Chen J
Zhonghua Wai Ke Za Zhi; 1998 Apr; 36(4):247-8. PubMed ID: 11825381
[TBL] [Abstract][Full Text] [Related]
15. Long-term results of intravesical N-CWS therapy for preventing bladder cancer recurrence after operation.
Chen S; Lin Z; Ye C; Xu E
Chin Med J (Engl); 1996 Nov; 109(11):890-1. PubMed ID: 9275378
[No Abstract] [Full Text] [Related]
16. Can intravesical bacillus Calmette-Guérin reduce recurrence in patients with superficial bladder cancer? A meta-analysis of randomized trials.
Han RF; Pan JG
Urology; 2006 Jun; 67(6):1216-23. PubMed ID: 16765182
[TBL] [Abstract][Full Text] [Related]
17. [The use of BCG vaccine for preventing recurrences of superficial bladder cancer].
Tkachuk VN; al-Shukri AKh; al-Khani F
Urol Nefrol (Mosk); 1996; (2):23-5. PubMed ID: 8677547
[TBL] [Abstract][Full Text] [Related]
18. [The need of prolonged BCG treatment in superficial bladder cancer is suggested by the development of a peripheral immune response induced by BCG].
Shekarsarai H; Zlotta AR; Drowart A; Van Vooren JP; De Cock M; Pirson M; Palfliet K; Jurion F; Vanonckelen A; Simon J; Schulman CC; Huygen K
Acta Urol Belg; 1997 Mar; 65(1):1-4. PubMed ID: 9245197
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of superficial bladder tumors with intravesical BCG vaccine].
Damianov Kh; Engibarov A; Patrashkov T; Tonchev T; Chuchkova M
Khirurgiia (Sofiia); 1988; 41(2):23-8. PubMed ID: 3411877
[No Abstract] [Full Text] [Related]
20. Intravesical bacillus Calmette-Guerin therapy for stage T1 grade 3 transitional cell carcinoma of the bladder: recurrence, progression and survival in a study of 57 patients.
Peyromaure M; Guerin F; Amsellem-Ouazana D; Saighi D; Debre B; Zerbib M
J Urol; 2003 Jun; 169(6):2110-2. PubMed ID: 12771729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]